HowardTrachtmanMD

Pediatric Nephrology • New York, NY

Professor of Pediatrics, NYU School of Medicine

Join to view full profile

Dr. Trachtman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Trachtman's full profile

Already have an account?

Office
403 E34th St
Room 1-02
New York, NY 10016
Phone+1 646-501-2663

Fax+1 212-263-4053

Education & Training

Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Pediatric Nephrology, 1981 - 1983
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1980 - 1983
Tufts Medical CenterResidency, Pediatrics, 1978 - 1980
Perelman School of Medicine at the University of PennsylvaniaClass of 1978

Certifications & Licensure

PA State Medical License 1992 - Present
NY State Medical License 1981 - 2026
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Nephrology

Awards, Honors, & Recognition

New York Magazine: Top Doctors Castle Connolly, 2002-2003, 2005-2019
Top Doctors: New York Metro Area Castle Connolly, 2002-2014
Newsday - Top Doctors on Long Island Castle Connolly, 2008, 2010-2011
New York Magazine: Top Pediatricians Castle Connolly, 2003
Top MD Consumers Checkbook
Fellow (ASNF) American Society of Nephrology
Join now to see all

Clinical Trials

Pilot Study of Mycophenolate Mofetil in Congenital Uropathies Start of enrollment: 2002 Mar 01
Completed
Phase 1
Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS) Start of enrollment: 2005 Jul 01
Completed
Phase 1
International Registry and Biorepository for TMA(Thrombotic Microangiopathy) Start of enrollment: 2007 Jan 01
Terminated
Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial Start of enrollment: 2008 Dec 01
Completed
Phase 2
Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor Start of enrollment: 2008 Dec 01
Terminated
Phase 1
Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5 Start of enrollment: 2008 Dec 01
Withdrawn
Phase 1
Reduction of Night-time Blood Pressure in Pediatric Renal Transplant Recipients Start of enrollment: 2009 Nov 01
Completed
Phase 2, Phase 3
Nephrotic Syndrome Study Network Start of enrollment: 2010 Apr 01
Recruiting
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant Start of enrollment: 2012 Jun 01
Completed
Phase 1
Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis Start of enrollment: 2014 Mar 01
Completed
Phase 2
A Study of RE-021 in Patients With Focal Segmental Glomerulosclerosis Start of enrollment: 2013 Jul 01
Efficacy of a Gluten-free Diet in Difficult to Manage Nephrotic Syndrome: Utility of Plasma Zonulin Levels as a Predictive Biomarker Start of enrollment: 2017 Dec 01
Completed
Join now to see all

Publications & Presentations

PubMed

12 citations
Comparing Kidney Health Outcomes in Children, Adolescents, and Adults With Focal Segmental Glomerulosclerosis.
Debbie S Gipson, Jonathan P Troost, Cathie Spino, Samara Attalla, Joshua Tarnoff
JAMA Network Open. 2022-08-01
69 citations
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease
Laura H. Mariani, Andrew S. Bomback, Pietro A. Canetta, Michael F. Flessner, Margaret E. Helmuth
American Journal of Kidney Diseases. 2019-02-01
141 citations
Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury.
Howard Trachtman, Erica Christen, Avital Cnaan, Jilma Patrick, Volker Mai
Pediatric Nephrology. 2006-06-01

Journal Articles

Does What Goes Around Always Come Around?
Howard Trachtman, MD, Journal of the American Society of Nephrology
DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS
Howard Trachtman, Peter Nelson, Abanti Chaudhuri, Jai Radhakrishnan, Olga Zhdanova, Debbie S Gipson, Tarak Srivastava, Kenneth Lieberman, Vimal Kumar Derebail, Jonatha..., Journal of the American Society of Nephrology

Press Mentions

Key Paediatric Milestone Reached in Dimerix’s Kidney-Disease Drug TrialSeptember 12th, 2024
Air Pollution Tied to Kidney Glomerular Disease ProgressionSeptember 11th, 2024
Tonsillectomy for the Management of Immunoglobulin A NephropathyMay 3rd, 2019
Join now to see all